SARS-CoV-2: a storm is raging

Pedersen, Savannah F., Ho, Ya-Chi·2020·Journal of Clinical Investigation

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Tempestade de citocinas no COVID-19: efeitos sistêmicos da desregulação imune
    Jean Carlos Fernando Besson, Adriani Ilse Gollo · 2023 · Brazilian Journal of Health Review
  2. Cell‐Based Biomaterials for Coronavirus Disease 2019 Prevention and Therapy
    Chuyu Li, Chenguang Wang, Hai‐Yan Xie, Lili Huang · 2023 · Advanced Healthcare Materials
  3. Data-Driven Generating Operator in SEIRV Model for COVID-19 Transmission
    Nadia Nadia, Afdol Zikri, Sila Rizqina, Kamal Khairudin Sukandar, Muhammad Fakhruddin, Chai Jian Tay, Nuning Nuraini · 2023 · Communication in Biomathematical Sciences
  4. Comparative study of TNF-α and IL-10 levels at different times of the course of COVID-19
    Arshak Ghazaryan, Vigen Asoyan, Alvard I. Hovhannisyan, Melanya Kozmoyan, Arevhat Karapetyan, Arpine Minasyan, Гюлазян Наира Мартуновна · 2023 · The Journal of Infection in Developing Countries
  5. Biomechanics Model to Characterize Atomic Force Microscopy-Based Virus–Host Cell Adhesion Measurements
    Jiajun Wang, Matthew Ziarnik, Xiao Hui Zhang, Anand Jagota · 2024 · The Journal of Physical Chemistry B
  6. Intervention strategies used by occupational therapists in older people hospitalized for COVID-19
    Natalia Paz Castillo-Núñez, Felipe Navarro, Ana Quintana, Andrea Lodeiro Encina, Thaís Rothier Duarte, Paulina Corona Bobadilla · 2025 · Cadernos Brasileiros de Terapia Ocupacional
  7. Carotid Body Size on CT Angiography in Patients With COVID-19 Pneumonia
    Kamber Göksu, Ahmet Vural, Ahmet Nedim Kahraman · 2025 · British Journal of Biomedical Science
  8. Oral MIB ‐626 (β Nicotinamide Mononucleotide) Safely Raises Blood Nicotinamide Adenine Dinucleotide Levels in Hospitalized Patients With COVID ‐19 and Acute Kidney Injury: A Randomized Controlled Trial
    Karol Mateusz Pencina, David E. Leaf, Rodrigo J. Valderrábano, Sushrut S. Waikar, Tapan S. Mehta, Yili Valentine Shang, Nancy K. Latham, Tejossy John, Elena Volpi, Dahlene N. Fusco et al. · 2025 · FASEB BioAdvances
  9. Ascertaining the claims and reality of probiotic usage as an adjuvant therapy against virus-induced respiratory tract infections
    Arpita Banerjee, Srija Pal, Arun Kumar Das, Pubali Dhar · 2025 · Food and Humanity
  10. Impact of maternal stress and COVID-19 exposure during pregnancy on offspring neurodevelopment: signature cohort 12 month follow-up
    Nathalia Garrido Torres, Andrés Román‐Jarrín, Julia Rider, María Alemany-Navarro, Blake A. Gibson, Beatriz de Felipe, Alberto Pérez‐Gómez, Lucas Cerrillos, Cristina Duque-Sánchez, Luis Alameda et al. · 2025 · European Child & Adolescent Psychiatry
  11. No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo
    Audray Fortin, Sandrine Huot, Elise Caron, Cynthia Laflamme, Amélie Pagliuzza, Nicolas Chomont, Caroline Gilbert, Baoshan Zhang, Peter D. Kwong, Marc Pouliot et al. · 2025 · PLoS ONE
  12. The metabolic-immune interface of obesity in Covid-19: a role for angiotensin ii and inflammatory cytokines
    Cíntia Maria Rodrigues, Juliane Duarte Santos, Bruna Caroline Chaves Garcia, Marcelo Henrique Fernandes Ottoni, Karine Beatriz Costa, Marina Luiza Baêta Costa, Vívian Gonzalez Figueiredo, Daniel Macedo, Danilo Bretas de Oliveira, Etel Rocha Vieira et al. · 2026 · Frontiers in Immunology
  13. Divergent Inflammatory Profiles but No Predictive Biomarkers of Psychiatric Sequelae After Viral Infection: A 12-Month Cohort Study
    Piotr Lorkiewicz, Justyna Adamczuk, Justyna Anna Kryńska, Mateusz Maciejczyk, Małgorzata Żendzian‐Piotrowska, Robert Flisiak, Anna M. Moniuszko-Malinowska, Napoleon Waszkiewicz · 2026 · International Journal of Molecular Sciences
  14. CXCL13/CXCR5 chemokine axis promotes antiviral CXCR5+CD19+ B Cells and follicular/effector CXCR5+CD4+ T Cells in the lungs associated with protection from severe and fatal COVID-19 following infection with pathogenic SARS-CoV-2 Delta variant
    Hawa Vahed, Aziz Alami Chentoufi, Swayam Prakash, Afshana Quadiri, Sweta Karan, Yassir Lekbach, Etinosa Omorogieva, Swena Patel, Jimmy Tadros, Emma Jane Liao et al. · 2026 · The Journal of Immunology
  15. The Failure of Pulmonary Oxygen Exchange in Severe Viral Lung Disease: Pneumolysis
    Gustavo Rafael Zubieta-Calleja, Felipe de Jesús Montelongo, Manuel Gabriel Romo Sanchez, Michele Samaja, Natalia Zubieta-DeUrioste · 2026 · Oxygen
  16. A built-in signal probe-enhanced molecularly imprinted acupuncture needle sensor for ultrasensitive detection of SARS-CoV-2 spike protein
    Jia Jie Li, Cairui Zhang, Jie Chen, Maofeng Wang, Khang Cao Nguyen, Hongying Liu, 阮战伟 · 2026 · Microchemical Journal
  17. SARS-CoV-2: una nueva amenaza
    Cristina A. López Rodríguez, Marc Boigués, Bibiana Quirant‐Sánchez, Aina Teniente‐Serra, Joan Climent Martí, Eva María Martínez-Cáceres · 2020 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
  18. Dexamethasone in Treatment of Comorbid SARS-CoV-2 Patients Aged over 50 Years with Lung Injury over 50 %
    O. Yu. Zolnikova, Roman Vyacheslavovich Maslennikov, Vladimir T Ivashkin, Natiya Dzhakhaya, O. Kiseleva, N. D. Potskhverashvili, S. A. Shorokhova · 2021 · Russian Journal of Gastroenterology Hepatology Coloproctology
  19. COVID-19 Tedavisinde Mezenkimal Kök Hücrelerin Potansiyel Kullanımı Üzerine Kapsamlı Bir İnceleme
    Tuğçe Kurt, Isa SEVİNC, Feyza UYSAL, Elif DEMİRAY, Hilal Deniz Yilmaz, Yavuz Emre Arslan · 2021 · Türkiye Sağlık Enstitüleri Başkanlığı Dergisi
  20. Predictive hematological and immunological parameters associated with postpartum progressed Covid-19 disease
    Fatma Bozkurt, Ömer Çoşkun, Sevda Yeleç · 2021 · African Health Sciences
  21. COVID-19 Subclinical Infection and Immunity
    Joyce Weade Bartekwa, EE Abene, Pam Dachung Luka, Christopher Sabo Yilgwan, Nathan Y. Shehu · 2021 · Nigerian Journal of Medicine
  22. Relationship between myalgia and laboratory parameters in hospitalized patients with COVID-19
    Dilek YILMAZ OKUYAN, Meltem Karacan Gölen · 2022 · Journal of Contemporary Medicine
  23. Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
    Wen-Xin Wang, R. Jia, Jin-Wen Song, Xiao-Ning Zhang, Shuang Zhou, Fuzhen Wang, Jun-Liang Fu · 2022 · Frontiers in Microbiology
  24. STATUS OF COVID-19 IN THE WORST AFFECTED TWENTY COUNTRIES AND THE WORLD AT THE END OF 2020
    Rushikesh G. Joshi, Kiransinh Narendrasinh Rajput, Vikram H. Raval, Prashant Arya, Rinkal B. Gohil, Aanal N. Patani, Kalpesh L. Mahla, Jaimin B. Pandya, Rakeshkumar Ramanlal Panchal · 2021 · Towards Excellence
  25. Neutrophil-to-Lymphocyte Ratio and Comorbidities as Mortality Predictors for COVID-19 Patient at Dr. Moewardi Hospital Surakarta
    Lawly Arrel Dionnie Greatalya, Dian Ariningrum, Lukman Aryoseto · 2023 · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
  26. Erectile Dysfunction in Men Who Have Been Ill with COVID-19
    E.V. Luchytskyy, Vitaliy Luchytskiy, Galina Zubkova, V.M. Rybalchenko, I.I. Skladanna · 2022 · Health of Man
  27. Vision transformer-based deep learning techniques for improper face mask-wearing detection
    A. S. M. Muntaheen, Nuzhat Tabassum, Nusrat Sharmin · 2022 · IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE)
  28. Article Review on Histopathologic Features of Placenta and Adverse Outcome in Pregnant Women with COVID-19 Positive
    Gutu Belay · 2023 · Pathology and Laboratory Medicine
  29. Impact of clinico-biochemical and inflammatory biomarkers on the immunogenicity and efficacy of SARS-CoV-2 adenoviral vaccine: a longitudinal study
    Sabhiya Majid, Mosin Saleem Khan, Najila Nisar, Javid A Bhat, Inaamul Haq, Muhammad Salim Khan · 2023 · Journal of Circulating Biomarkers
  30. The correlation between aminotransferase enzyme levels, neutrophil-to-lymphocyte ratio, absolute lymphocyte count and the severity of Covid-19
    Sas Al, Budi Santosa, Lisyani Suromo, Satriya Pranata · 2023 · Scripta Medica
  31. The rs2228145 Variant of the Interleukin-6 Receptor (IL-6R) Gene Impacts on In Vitro Cellular Responses to SARS-CoV-2 VOC B1.1.7 Recombinant Spike Protein
    Saira Sarwar, Rebecca Aicheler, Lee Butcher, Katie Rees, Stephen Potter, Richard S. Rowlands, Richard Webb · 2023 · COVID
  32. Neutrophil- and platelet-lymphocyte ratios as valuable prognostic biomarkers in ICU COVID-19 patients
    Maha Fathy, Ahmad Al-Jarallah, Noha A. Doudar, Hoda Ramadan Reyad, Shaimaa Ahmed Senosy, Doaa Ahmed, Zahraa Mustafa, Asmaa M. Othman · 2023 · Egyptian Journal of Medical Research
  33. Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial
    Morteza Pourahmad, Amir Aria, Mahnaz Momenzadeh, Fatemeh Nikoukar, Behrooz Ataei, Farzin Khorvash, Manizhe Shams, Kiana Shahzamani, Sara Nasirharandi · 2024 · Journal of Nephropharmacology
  34. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients
    Mohammad Asrar Izhari · 2024 · Infection and Drug Resistance
  35. Pathophysiology And Clinical Manifestation of Cytokine Storm
    Ali Y. Khudhair, Ahmed Hussein Zwamel, Maha Chasib Munshid, Ali A. Al-fahham · 2024 · INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH
  36. Risk of neonatal SARS-CoV-2 infection: a retrospective cohort study based on infected mothers with gestational diabetes mellitus
    Jing Ni, Yongfei Zheng, Jiaqi Tian, Lin Zhang, Shuyin Duan · 2025 · Frontiers in Endocrinology
  37. COVID-19 and Rheumatic Diseases: Practical Issues
    Ho So, Chi Chiu Mok · 2020 · Journal of Clinical Rheumatology and Immunology
  38. A case of cytokine hemofiltration and extracorporeal life support as treatment of coronavirus disease 2019 (COVID-19) respiratory failure
    Omar H. Al-Qudsi, Bryan A. Whitson, Amar M. Bhatt, Sheila Chucta, Ravi S. Tripathi · 2020 · Journal of Thoracic and Cardiovascular Surgery
  39. Treatment of psoriasis – unburdened by fear during SARS-CoV2 menace
    Teodora Larisa Timiș, Ioan Alexandru Florian, Ștefan Cristian Vesa, Remus-Ioan Orăsan · 2020 · Journal of Dermatological Treatment
  40. COVID-19: An Update Regarding the Quest for Finding an Effective Cure
    Fahed S Bangash, Gulalei Saeed, Palwasha Shahab, Aneeqa Waheed · 2020 · Cureus
  41. Doxycycline: a new treatment option for COVID-19
    Ismail Anwar, Eman K. E. Anwer, Mohamed AbdAllah · 2020 · Alexandria Journal of Medicine
  42. Opportunistic physiology: inserting physiology and pathophysiology content into virtually delivered clinical rotations
    Thad E. Wilson, Minal Mulye, Samina Akbar · 2020 · AJP Advances in Physiology Education
  43. Analysis of neutrophil to lymphocytes ratio (NLR), platelet to lymphocytes ratio (PLR) and Ct value as a prognostic tool in Covid-19 patients-A cross sectional study in southern Rajasthan
    Dr. Namita Goyal, Lakhan Poswal, Gunjan Bhatia, Priyanka Kumari, Vijay Singh Rajak, Dr. Dharmendra Garg · 2020 · International Journal of Clinical and Diagnostic Pathology
  44. How can clinical immunology laboratories contribute to the management of severe COVID-19 cases in limited resource contexts?
    Brahim Admou, Abdelhamid Hachimi, Mohamed Abdenasser Samkaoui · 2020 · African Journal of Laboratory Medicine
  45. Herd immunity against COVID-19: is it enough to stop a second wave?
    Mohamed AbdAllah, Ahmed Cordie · 2020 · New Microbes and New Infections
  46. Патогенетически обоснованная профилактика цереброваскулярных заболеваний у больных с коронавирусной инфекцией
    М А Трещинская, O.Ye. Kononov, И В Бельская · 2020 · INTERNATIONAL NEUROLOGICAL JOURNAL
  47. Guía de atención remota para pacientes pediátricos con COVID-19
    Juan Pablo Jaldín, Nicolas Ortiz Flores, Carlos Alberto Paz-Román, Mauricio Peña Rodríguez · 2020 · Gaceta Médica Boliviana
  48. Cellular Therapy as Promising Choice of Treatment for COVID-19
    Duygu Koyuncu Irmak, Erdal Karaöz · 2021 · IntechOpen eBooks
  49. Hémostase et COVID-19
    Hamid Merdji, Laurent Sattler, Sibylle Cunat, Ferhat Meziani, Julie Helms · 2021 · Médecine Intensive Réanimation
  50. SECCION VI. Población pediátrica
    Carlos Humberto Saavedra Trujillo · 2021 · Infectio
  51. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study
    Sonia Beeckmans, Edilbert VAN DRIESSCHE · 2021 · Frontiers in Molecular Biosciences
  52. Therapeutic Potential of Traditional Indian Herbal Medicine in COVID-19: A Narrative Review
    Snigdha Singh, Danish Javed, Sukhes Mukherjee, Rishabh Mittal, Nidhi Chourasia, Amit Agrawal, Ashwin Laxmikant Kotnis · 2021 · Hospital Practices and Research
  53. Pathophysiologie von COVID-19 und deren mögliche Bedeutung für Long-COVID
    Johannes Scherr · 2021 · Sports Orthopaedics and Traumatology
  54. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19
    Yousef Rasmi, Ghader Babaei, Muhammad Farrukh Nisar, Hina Noreen, Shiva Gholizadeh‐Ghaleh Aziz · 2021 · Comparative Clinical Pathology
  55. COVID-19 impact on liver: inter-organ cross-talk in an acute inflammation
    Dipesh Kumar Yadav, Alina Singh, Rajesh Kumar Yadav, Xing Huang, Xueli Bai, Liang Tingbo · 2021 · Journal of Patan Academy of Health Sciences
  56. Impact of three consecutive intravenous doses of tocilizumab in severe COVID-19 pneumonia: a retrospective cohort study
    Raihan Rabbani, Md Jahidul Hasan, Ahmad Mursel Anam, Shihan Mahmud Redwanul Huq · 2021 · Microbes Infection and Chemotherapy
  57. Seroprevalence of COVID-19 IgG Antibody in Resident and Fellow Physicians in Milwaukee, Wisconsin: Analysis of a Cross-Sectional Survey
    Dennis J Baumgardner, A Schwank, Jessica J.F. Kram, Wilhelm Lehmann, Jacob Bidwell, Tricia La Fratta, Kenneth Copeland · 2022 · Journal of patient-centered research and reviews
  58. Classification Models for Medical Data with Interpretative Rules
    Xinyue Xu, Xiang Ding, Zhenyue Qin, Yang Liu · 2021 · Lecture notes in computer science
  59. Deep venous thrombosis and acute pericarditis associated with severe acute respiratory syndrome coronavirus 2 infection in a Congolese infant with sickle cell disease: a case report
    Toni Kasole Lubala, Tony Kayembe‐Kitenge, Paul Makinko Ilunga, Luguette Kalenga, Hénoch Kachil, Axel Kayembe, Augustin Mulangu Mutombo, Mick Yapongombo Shongo · 2022 · Journal of Medical Case Reports
  60. Potential histopathological and immunological effects of SARS-CoV-2 on the liver
    Mashael Mashal Alnamshan · 2022 · Brazilian Journal of Biology
  61. Face Mask Identification using Transfer Learning Techniques
    A Priyadarshini, J Aravinth · 2022 · International Conference on Electronics and Sustainable Communication Systems (ICESC)
  62. Capillary Regression, A Key Pathogenic Feature of COVID-19 Infection?
    George E. Davis, Courtney T. Griffin · 2020 · Preprints.org
  63. Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort Study
    Ooi Say Tat, Purnima Parthasarathy, Yi Lin, Valliammai D O Nallakaruppan, Shereen Jia Huey Ng, Tan Teck Choon, Low Serena, Tang Terence · 2020 · medRxiv
  64. COVID-19: better trustworthiness of clinical evidence through clinical trials and systematic reviews
    Álvaro Nagib Atallah · 2020 · Sao Paulo Medical Journal
  65. Old Drugs for JAK-STAT Pathway Inhibition in COVID-19
    Mohammad Reza Dayer · 2020 · arXiv (Cornell University)
  66. Characteristics of Peripheral Blood Cells in COVID-19 Patients Revealed by a Retrospective Cohort Study
    Xunliang Tong, Anqi Cheng, Xueting Yuan, Xuefeng Zhong, He Wang, Wei Zhou, Xiaomao Xu, Yanming Li · 2020
  67. The COVID-19 Mortality Puzzle: A Single Explanation for Why Men, Elders, People of Color, and Hypertensives are Dying from Coronavirus
    Felice L. Bedford · 2020 · SSRN Electronic Journal
  68. Hypothesis of Potential Evolution of SARS-CoV-2 through Hybridization of SARS-CoV-1 with Saccharomyces cerevisiae and Mycobacterium avium naturally inside an immunocompromised Pangolin
    Shimaa M. Abdelgawad · 2020
  69. Are Aspirin and Apixaban Sufficient to Prevent Immunothrombosis in COVID-19?
    Kate Chander Chiang, Srinivasa T. Reddy, Ajay Kumar Gupta · 2020 · SSRN Electronic Journal
  70. Systematic temporal analysis of peripheral blood transcriptomes using TrendCatcher identifies early and persistent neutrophil activation as a hallmark of severe COVID-19
    Xinge Wang, Mark A. Sanborn, Yang David Dai, Jalees Rehman · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  71. The efficacy of vaccines in the context of SARS-CoV-2 and its variants: Role of Spatio-temporal boundary
    Durbar Roy, Dipshikha Chakravortty, Saptarshi Basu · 2021 · medRxiv
  72. Prolific Induction of IL-6 in Human Cells by SARS-CoV-2-derived Peptide is Attenuated by Recombinant Human Anti-inflammatory Cytokines made in planta
    Pieter H. Anborgh, Igor Kolotilin, Nisha A. Owens, Abdulla Azzam Mahboob · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Evaluation of the Efficacy of Omega-3 Fatty Acids Formulations in the Lipopolysaccharide-Induced Acute Lung Inflammation Rat Model
    Chandrashekhar Kocherlakota, Nagaraju Banda, Arjun Narala, Akula Srinath, Kumar S.D. Kothapalli, James Thomas Brenna · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Preliminary Report of In vitro and In vivo Effectiveness of Dornase Alfa on SARS-CoV-2 Infection (Preprint)
    Hacer Kuzu Okur, Koray Yalçın, Cihan Taştan, Sevda Demir, Bulut Yurtsever, Gözde Sır Karakuş, Derya Dilek Kançağı, Utku Seyis, Rehile Zengin, Cansu Hemşinlioğlu et al. · 2020
  75. Extreme γ’ fibrinogen levels in COVID-19 patients
    David H. Farrell, Matthew R. Hudkins, Heather Hamilton, Samantha J. Underwood, Elizabeth N. Dewey, Diana E Kazmierczak, Steven C. Kazmierczak, William B. Messer, Akram Khan, Martin A. Schreiber · 2022 · medRxiv
  76. Stimulation of dysregulated IFN-β responses by aberrant SARS-CoV-2 small viral RNAs acting as RIG-I agonists
    Yohei Watanabe, Yasuha Arai, Itaru Yamanaka, Toru Okamoto, Ayana Isobe, Naomi Nakai, Naoko Kamimura, Tomo Daidoji, Takao Ono, Takaaki Nakaya et al. · 2022 · Research Square
  77. Remote management of osteoporosis in the first wave of the Covid-19 pandemic
    Gianmaria Salvio, Claudio Gianfelice, Francesca Firmani, Stefano Lunetti, Rossella Ferroni, Giancarlo Balercia, Gilberta Giacchetti · 2022 · Endocrine Abstracts
  78. A structure-based drug repurposing approach by considering the twenty four SARS-CoV2 Targets: A consensus scoring approach
    Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, Kikrusenuo Kiewhuo, Selvaraman Nagamani, Garikapati Narahari Sastry · 2022 · Research Square
  79. Host transcriptional responses and SARS-CoV-2 isolates from the nasopharyngeal samples of Bangladeshi COVID-19 patients
    Abul Bashar Mir Md. Khademul Islam, Md. Abdullah‐Al‐Kamran Khan, Rasel Ahmed, Md. Sabbir Hossain, Shah Md Tamim Kabir, Md. Shahidul Islam, AMAM Zonaed Siddiki · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Clinical management recommendations for paediatric dental patients in times of covid-19 - a review
    Shalini Garg, Anil Kumar Gupta, Sakshi Joshi, Ankit Srivastava, Shikha Dogra · 2020 · Indian Journal of Health Sciences and Care
  81. Ліпін за гіпоксичних станів: від експерименту до клініки (огляд літератури)
    N.V. Dobrelia, Alexander S. Khromov, Т. А. Бухтіарова · 2020 · Pharmacology and Drug Toxicology
  82. SARS-CoV-2: a new threat
    Cristina A. López Rodríguez, Marc Boigués, Bibiana Quirant‐Sánchez, Aina Teniente‐Serra, Joan Climent Martí, Eva María Martínez-Cáceres · 2020 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
  83. 42-Year-Old Patient With Severe COVID-19 Pneumonia and Cytokine Storm: Hurdles During Management
    Maksudul Islam Majumder, Sumaiya Akter, Halima Sadia, Ishrat Binte Reza, M Zahir Uddin, HAM Nazmul Ahasan · 2020 · Journal of Medicine
  84. How COVID Threatens IMGs’ Residency Training
    Shawn Y Forrester · 2021 · Springer eBooks
  85. Comments on potential re-purposing of medicines against high-altitude illnesses towards SARS-CoV2: possibilities and pitfalls
    Yasmin Ahmad, Subhojit Paul, Rajeev Kumar Varshney, Bhuvnesh Kumar · 2021 · Journal of Proteins and Proteomics
  86. Study Protocol for DeCOmPRESS: Defining the Disease Course and Immune Profile of COVID-19 in the Immunosuppressed Patient
    Emma J. Leacy, Gareth Brady, Niall P. Conlon, Jennifer Scott, Jean Dunne, Thomas Phelan, William J. McCormack, Matthew Dallas Griffin, Alan Kennedy, Alyssa Verrelli et al. · 2021 · HRB Open Research
  87. Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
    Christophe Richez, René‐Marc Flipo, Françis Berenbaum, Alain G Cantagrel, Pascal Claudepierre, Françoise Debiais, Philippe Dieudé, Philippe Goupille, Christian Roux, Thierry Schaeverbeke et al. · 2021 · Revue du Rhumatisme
  88. Evaluation of Health Status of Children with Autoinflammatory Diseases During COVID-19 Pandemic
    Fatih Haşlak, Mehmet Yıldız, Amra Adroviç, Sezgin Şahin, Oya Köker, Ayten Aliyeva, Kenan Barut, Özgür Kasapçopur · 2020
  89. Evaluation Of Clinical, Laboratory And Radiological Findings In Pediatric Covid-19 Cases And Their Relation With RT-PCR Result
    Muhammet Asena, İlyas Yolbaş, Murat Kanğın · 2021
  90. Transmissibility: To be or not to be
    Amlan Kanti Ray, Madhab Chandra Das, Madhumita Roychoudhury, Sujata Das, Sudeshna Bakshi, Nitish Mondal · 2021 · Journal of Reproductive Healthcare and Medicine
  91. A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19
    Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A. Ferns, Majid Khazaei, Soodabeh Shahidsales, Amir Avan · 2021 · Infectious Disorders - Drug Targets
  92. A novel, anatomy-similar in vitro model of 3D airway epithelial for anti-coronavirus drug discovery
    Yaling Zhang, Dingailu Ma, Jitao David Zhang, Xinan Liu, Qihui Zhu, Li Wang, Lu Gao · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Breakthroughs in SARS-CoV-2-monoclonal antibodies development
    Yusuf Muhammed, Mkpouto Pius, Bashiru Eya Sani, Bulus Timothy, Jafar Usman, Musa Garba · 2021 · Novel Research in Microbiology Journal
  94. Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR.
    Tanmay Saraiya, Dimitris Labrou, Konstantinos E. Farsalinos, Konstantinos A. Poulas · 2021
  95. Can be Protective Effect Melatonin against covid-19 Induced Gastrointestinal and Liver Damage?
    Ahmet Özer Şehirli, Tuğrul Çakır, Cebrail Akyüz, Serkan Sayıner · 2021 · Acta Scientific Gastrointestinal Disorders
  96. SARS-CoV-2の病態生理
    史雄 中村, 綾子 石津 · 2021 · 東京女子医科大学雑誌
  97. A RETROSPECTIVE COHORT STUDY ASSESSING THE EFFECTIVENESS OF TOCILIZUMAB IN IMPROVING OXYGENATION IN MODERATE TO SEVERELY ILL COVID-19 PATIENTS ADMITTED IN A TERTIARY CARE CRITICAL CARE UNIT
    Debasish Ghosh, Paramita Basu · 2021 · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
  98. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal
    Kang Jin · 2021 · PubMed
  99. Obesity and exercise immunology: implication in times of COVID-19 pandemic
    Guilherme Gomes Azizi, Marco Antônio Orsini, Sérgio Duarte Dortas, Sandro de Albuquerque Cerbino · 2020 · Revista Brasileira de Fisiologia do Exercício
  100. Mapping the recovery of critically ill COVID19 patients by high-dimensional profiling identifies longitudinal blood immunotypes
    Pier-Andrée Penttilä, Sofie Van Gassen, Dena Panovska, Lore Vanderbeke, Yannick Van Herck, Katrien L. A. Quintelier, Annelies Emmaneel, Jessica Filtjens, Bert Malengier‐Devlies, Kourosh Ahmadzadeh et al. · 2020